- WVE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Wave Life Sciences (WVE) 10-K/A2018 FY Annual report (amended)
Filed: 29 Apr 19, 5:09pm
Exhibit 31.2
CERTIFICATION PURSUANT TO
SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
I, Keith C. Regnante, certify that:
1. | I have reviewed this Amendment No. 1 to Annual Report on Form10-K/A of Wave Life Sciences Ltd. |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: April 29, 2019
/s/ Keith C. Regnante |
Keith C. Regnante |
Chief Financial Officer (principal financial officer and principal accounting officer) |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.